Company: SCLXW
Filing Date: 2025-10-28
Form Type: PRE 14A
Source: 0001193125-25-253884
Chunk: 23

Company: Scilex Holding Co
Filing Date: 2025-10-28
Form: PRE 14A
Chunk 23
---
 |              | — |     |               | — |     |              | 11,651 | -1 |     |       |  1,261,651 |    |
| Executive Chairperson                                                  |     |      | 2023 |     |        |   821,465 |     |       | — |     |        | — |     |        | 33,034,320 |     |              | — |     |               | — |     |              | 63,965 | -3 |     |       | 33,919,750 |    |
| Stephen Ma                                                             |     |      | 2024 |     |        |   600,000 |     |       | — |     |        | — |     |        |          — |     |              | — |     |               | — |     |              | 13,821 | -1 |     |       |    613,821 |    |
| Chief Financial Officer, Senior Vice President, Secretary and Director |     |      | 2023 |     |        |   470,676 |     |       | — |     |        | — |     |        |  1,427,260 |     |              | — |     |               | — |     |              |  2,769 |    |     |       |  1,900,705 | -4 |

| (1) | Represents (a) matching contributions made to the named executive officer under the Company’s 401(k) 
 plan and (b) life insurance premiums paid by the Company for his benefit.                            |

| (2) | Represents (a) matching contributions made to Mr. Shah under the Company’s 401(k) plan,               
 (b) accrued unused paid time off and (c) life insurance premiums paid by the Company for his benefit. |

| (3) | Represents compensation expense allocated by Sorrento Therapeutics, Inc. (“Sorrento”) to (and paid      
 by) the Company for services provided by Dr. Ji (on behalf of Sorrento) to the Company in January 2023. |

| (4) | Mr. Ma was appointed as our Chief Financial Officer, Senior Vice President and Secretary on                                                                                                                                                        
 September 22, 2023. Represents compensation paid or accrued as our Chief Accounting Officer (from May 2023 until his appointment as our Chief Financial Officer, Senior Vice President and Secretary in September 2023